Your browser doesn't support javascript.
loading
EphA2: A promising therapeutic target in breast cancer.
Zhao, Ping; Jiang, Dewei; Huang, Yunchao; Chen, Ceshi.
Afiliación
  • Zhao P; Department of the First Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650118, China.
  • Jiang D; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.
  • Huang Y; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650118, China. Electronic address: huangych2001@aliyun.com.
  • Chen C; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China; KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institut
J Genet Genomics ; 48(4): 261-267, 2021 04 20.
Article en En | MEDLINE | ID: mdl-33962882

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor EphA2 / Terapia Molecular Dirigida / Carcinogénesis Límite: Female / Humans Idioma: En Revista: J Genet Genomics Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor EphA2 / Terapia Molecular Dirigida / Carcinogénesis Límite: Female / Humans Idioma: En Revista: J Genet Genomics Año: 2021 Tipo del documento: Article País de afiliación: China